1. Home
  2. NAMSW vs SWVLW Comparison

NAMSW vs SWVLW Comparison

Compare NAMSW & SWVLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMSW
  • SWVLW
  • Stock Information
  • Founded
  • NAMSW N/A
  • SWVLW N/A
  • Country
  • NAMSW Netherlands
  • SWVLW United Arab Emirates
  • Employees
  • NAMSW 29
  • SWVLW 312
  • Industry
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • SWVLW Business Services
  • Sector
  • NAMSW Health Care
  • SWVLW Consumer Discretionary
  • Exchange
  • NAMSW Nasdaq
  • SWVLW Nasdaq
  • Market Cap
  • NAMSW N/A
  • SWVLW N/A
  • IPO Year
  • NAMSW N/A
  • SWVLW N/A
  • Fundamental
  • Price
  • NAMSW $9.45
  • SWVLW $0.02
  • Analyst Decision
  • NAMSW
  • SWVLW
  • Analyst Count
  • NAMSW 0
  • SWVLW 0
  • Target Price
  • NAMSW N/A
  • SWVLW N/A
  • AVG Volume (30 Days)
  • NAMSW N/A
  • SWVLW N/A
  • Earning Date
  • NAMSW N/A
  • SWVLW N/A
  • Dividend Yield
  • NAMSW N/A
  • SWVLW N/A
  • EPS Growth
  • NAMSW N/A
  • SWVLW N/A
  • EPS
  • NAMSW N/A
  • SWVLW N/A
  • Revenue
  • NAMSW N/A
  • SWVLW N/A
  • Revenue This Year
  • NAMSW N/A
  • SWVLW N/A
  • Revenue Next Year
  • NAMSW N/A
  • SWVLW N/A
  • P/E Ratio
  • NAMSW N/A
  • SWVLW N/A
  • Revenue Growth
  • NAMSW N/A
  • SWVLW N/A
  • 52 Week Low
  • NAMSW N/A
  • SWVLW N/A
  • 52 Week High
  • NAMSW N/A
  • SWVLW N/A
  • Technical
  • Relative Strength Index (RSI)
  • NAMSW 50.58
  • SWVLW N/A
  • Support Level
  • NAMSW $9.40
  • SWVLW N/A
  • Resistance Level
  • NAMSW $10.14
  • SWVLW N/A
  • Average True Range (ATR)
  • NAMSW 0.48
  • SWVLW 0.00
  • MACD
  • NAMSW 0.06
  • SWVLW 0.00
  • Stochastic Oscillator
  • NAMSW 29.67
  • SWVLW 0.00

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About SWVLW Swvl Holdings Corp Warrant

Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. Its technology and services provide commuters, travelers and businesses with an alternative to traditional public transportation, taxi companies or other ridesharing companies. The company's core product is B2C Swvl Retail offering, which provides riders with a network of minibuses and other vehicles running on fixed or semi-fixed routes within cities. Commuters use its Swvl mobile application to book rides between pre-defined pick-up points located throughout the city.

Share on Social Networks: